Na+/K+-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection

Na+/K+-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), identified for the first time in Wuhan, China, causes coronavirus disease 2019 (COVID-19), which moved from epidemic status to becoming a pandemic. Since its discovery in December 2019, there have been countless cases of mortality and mor...

Full description

Bibliographic Details
Main Authors: Kauê Francisco Corrêa Souza e Souza, Bianca Portugal Tavares Moraes, Izabel Christina Nunes de Palmer Paixão, Patrícia Burth, Adriana Ribeiro Silva, Cassiano Felippe Gonçalves-de-Albuquerque
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
SARS-CoV-2
COVID-19
cardiac glycosides
Na+
K+ ATPase
molecular target
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.624704/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.624704/full

Similar Items